FENNEC PHARMACEUTICALS INC. - FENC

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q1 2026 · Q4 2025
Value (USD)
Total reported value ($000)
$108.1M
QoQ value delta ($000)
-$11.53M (-9.64%)
Implied price effect (QoQ)
-18.87%
Shares
Total shares
17,305,844
QoQ shares delta
+1,767,338 (+11.37%)
Total shares held by funds (by quarter)

Market chart (FENC)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q1 2026)

Top 25 only Full list
Partial Q1 2026 data: 91 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
Rosalind Advisors, Inc. 17,885 2,908,201 7.19%
Southpoint Capital Advisors LP 16,880 2,744,741 0.35%
Solas Capital Management, LLC 15,265 2,482,198 8.78%
AIGH Capital Management LLC 12,186 1,981,501 1.66%
BlackRock, Inc. 8,414 1,368,176 0.0%
VANGUARD GROUP INC 8,220 1,067,651 0.0%
VANGUARD CAPITAL MANAGEMENT LLC 5,517 897,144 0.0%
AWM Investment Company, Inc. 4,428 720,135 0.49%
GEODE CAPITAL MANAGEMENT, LLC 2,286 371,738 0.0%
STATE STREET CORP 2,208 359,055 0.0%
Potomac Capital Management, Inc. 1,380 224,400 1.2%
MORGAN STANLEY 1,298 211,108 0.0%
VANGUARD PORTFOLIO MANAGEMENT LLC 1,036 168,473 0.0%
CITADEL ADVISORS LLC 944 153,610 0.0%
NORTHERN TRUST CORP 935 152,123 0.0%
Lion Point Capital, LP 691 112,434 4.13%
Cornerstone Capital, Inc. 645 105,000 0.06%
GENDELL JEFFREY L 510 83,024 0.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 510 83,005 0.01%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 390 63,537 0.0%
Nuveen, LLC 374 60,948 0.0%
THOMPSON SIEGEL & WALMSLEY LLC 352 57,226 0.01%
Squarepoint Ops LLC 347 56,510 0.0%
GOLDMAN SACHS GROUP INC 342 55,664 0.0%
Eleva Capital SAS 327 53,234 0.1%